Cat.#: ASSD-171
Description | Ionomycin calcium salt is a potent calcium ionophore that shows selectivity for Ca2+ over Mg2+ and K+. The compound acts as a Ca2+ carrier and is the calcium salt of ionomycin. Ionomycin can enhance Ca2+ influx and increase intracellular Ca2+ concentration. Also induces apoptosis. |
Size | 1mg, 5mg |
Chemical Name | (4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-11,19,21-Trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-10,16-docosadienoic acid calcium salt |
Molecule Weight | 747.08 |
Molecular formula | C41H70CaO9 |
CAS Number | 56092-82-1 |
PubChem identifier | 6446270 |
MDL Number | MFCD00083634 |
Purity | >98% |
Solubility | Soluble in ethanol (100 mM) and DMSO (25 mM) |
Form | White to off-white |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-203 | Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (AC203) | 5 mg | inquiry |
ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg | inquiry |
ASSD-188 | Dansyl Chloride (AC188) | 1 g | inquiry |
ASSD-139 | Adenosine A1AR Affinity-Based Probe (AfBP) (AC139) | 50 μg | inquiry |
ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
ASSD-208 | NBD-X, succinimidyl ester (AC208) | 100 mg | inquiry |
ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
ASSD-137 | CCR2 covalent NAM (AC137) | 50 μg | inquiry |
ASSD-110 | Picro Sirius Red Stain Kit (AC110) | 1 kit, 100 tests | inquiry |
ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.